STAT3 and breast carcinoma: ERK1/2 together with STAT3 and AKT also promotes the functional proliferation and activity of MDSCs in breast cancer, where the three pathways are down-regulated by the onco-suppressor aminoacyl-tRNA synthetase-interacting multifunctional protein 1 (AIMP1) [171].